Transcriptional shut-off of MAP kinase signaling enables pluripotency maintenance during diapause
ChIP-seq / ATAC-seq (genome binding and open chromatin) · mouse · 83 samples
- What it is
- ChIP-seq / ATAC-seq (genome binding and open chromatin)Where proteins bind the genome, or which regions are open and active.
- Organism
- Mus musculus (mouse)
- Samples
- 83 samples: 17 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- The signaling cascade of induction and maintenance of ES cell diapauseResearch square · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE249392_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: Look for peak files (.bed, .narrowPeak) and signal tracks (.bigWig) among the supplementary files; the raw reads are on ENA.
Also filed as BioProject PRJNA1048951 and SRA study SRP514003. Searching any of these in the dataset finder brings you back here.
Supports a case/control comparison: 12 samples read as cases, 40 as controls.
How we read this: 17 replicated groups read from 83 sample titles; they account for 53 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM7943528 Control 60min DMSO biological replicate 1 Control 60min DMSO
- GSM7943529 Control 60min DMSO biological replicate 2 Control 60min DMSO
- GSM7943530 Control 60min DMSO biological replicate 3 Control 60min DMSO
- GSM7943531 Control for I-BETR ES cells biological replicate 1 Control for I-BETR ES c…
- GSM7943532 Control for I-BETR ES cells biological replicate 2 Control for I-BETR ES c…
- GSM7943533 Control for I-BETR ES cells biological replicate 3 Control for I-BETR ES c…
- GSM7943534 Control for I-BETR ES cells biological replicate 4 Control for I-BETR ES c…
- GSM7943535 I-BETR ES cells biological replicate 1 I-BETR ES cells
- GSM7943536 I-BETR ES cells biological replicate 2 I-BETR ES cells
- GSM7943537 I-BETR ES cells biological replicate 3 I-BETR ES cells
- GSM7943538 I-BETR ES cells biological replicate 4 I-BETR ES cells
- GSM7943551 WT control for 30min Torin1 treatment biological replicate 1 WT control for 30min To…
- GSM7943552 WT control for 30min Torin1 treatment biological replicate 2 WT control for 30min To…
- GSM7943553 WT control for 30min Torin1 treatment biological replicate 3 WT control for 30min To…
- GSM7943554 Torin1 treated 30min biological replicate 1 Torin1 treated 30min
- GSM7943555 Torin1 treated 30min biological replicate 2 Torin1 treated 30min
- GSM7943556 Torin1 treated 30min biological replicate 3 Torin1 treated 30min
- GSM7943557 WT control for 60min Torin1 treatment biological replicate 1 WT control for 60min To…
- GSM7943558 WT control for 60min Torin1 treatment biological replicate 2 WT control for 60min To…
- GSM7943559 WT control for 60min Torin1 treatment biological replicate 3 WT control for 60min To…
- GSM7943560 Torin1 treated 60min biological replicate 1 Torin1 treated 60min
- GSM7943561 Torin1 treated 60min biological replicate 2 Torin1 treated 60min
- GSM7943562 Torin1 treated 60min biological replicate 3 Torin1 treated 60min
- GSM7943563 WT control for 120min Torin1 treatment biological replicate 1 WT control for 120min T…
- GSM7943564 WT control for 120min Torin1 treatment biological replicate 2 WT control for 120min T…
- GSM7943565 WT control for 120min Torin1 treatment biological replicate 3 WT control for 120min T…
- GSM7943566 Torin1 treated 120min biological replicate 1 Torin1 treated 120min
- GSM7943567 Torin1 treated 120min biological replicate 2 Torin1 treated 120min
- GSM7943568 Torin1 treated 120min biological replicate 3 Torin1 treated 120min
- GSM7943569 WT control for 360min Torin1 treatment biological replicate 1 WT control for 360min T…
- GSM7943570 WT control for 360min Torin1 treatment biological replicate 2 WT control for 360min T…
- GSM7943571 WT control for 360min Torin1 treatment biological replicate 3 WT control for 360min T…
- GSM7943572 Torin1 treated 360min biological replicate 1 Torin1 treated 360min
- GSM7943573 Torin1 treated 360min biological replicate 2 Torin1 treated 360min
- GSM7943574 Torin1 treated 360min biological replicate 3 Torin1 treated 360min
- GSM7943581 Control for 15min Torin1 treatment biological replicate 1 Control for 15min Torin…
- GSM7943582 Control for 15min Torin1 treatment biological replicate 2 Control for 15min Torin…
- GSM7943583 Control for 15min Torin1 treatment biological replicate 3 Control for 15min Torin…
- GSM7943584 Control for 30min Torin1 treatment biological replicate 1 Control for 30min Torin…
- GSM7943585 Control for 30min Torin1 treatment biological replicate 2 Control for 30min Torin…
+ 43 more — browse all 83 samples with per-sample file links →
- GSE269920 Transcriptional shut-off of MAP kinase signaling enables pluripotency maintenance during diapause [ChIP-Seq] 30 samples shares map, pluripotency, maintenance, shut-off, diapause, enables, kinase
- GSE225240 Reevaluation by CRISPR-Cas9 approach reveals multiple lincRNAs dispensable for pluripotency maintenance and SNORA73 essential for pluripotency exit 13 samples shares pluripotency, maintenance
- GSE225237 Reevaluation by CRISPR-Cas9 approach reveals multiple lincRNAs dispensable for pluripotency maintenance and SNORA73 essential for pluripotency exit (RNA-Seq) 12 samples shares pluripotency, maintenance
- GSE298240 Inhibition of p38 MAPK after repetitive mild TBI ameliorates immune signaling and behavioral deficit 58 samples shares map
- GSE278577 β2 ADRENERGIC SIGNALING STIMULATES EARLY IL-1β SECRETION IN MACROPHAGES BY INDUCING MAPK-DEPENDENT Il1b TRANSCRIPTION [RNA-Seq] 30 samples shares map
- GSE330842 GALNT3-deletion suppresses inflammation-associated fibrosis to ameliorates chronic kidney disease via inactivating the TNF-α/NF-kB/MAPK signaling pathway 9 samples shares map
- GSE307773 Oncogenic MAPK signalling induces epithelial cell state change and therapeutic resistance in vivo [RNA-Seq] 175 samples shares map
- GSE217970 Mapping putative enhancers in mouse oocyte and early embryo reveals TCF3/12 as key folliculogenesis regulators 164 samples shares map
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.